Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU26F0A95
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,882
Award facts
- Contract value 100% obligated
- $1,882.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $1,882.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. This delivery order, issued on October 19, 2025, with an ultimate completion date of October 20, 2025, represents a firm fixed-price purchase with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group operates as a critical supplier within the Department of Defense pharmaceutical supply chain, distributing a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support military healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency, designated SPE2DR, which carries a $500 million ceiling value and extends through December 31, 2036. The broader PPV-G GEN V program, valued at $30.3 billion, establishes multiple regional prime vendor contractors to ensure reliable pharmaceutical supply for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26F0A95?
SPE2DU26F0A95 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 19, 2025.
How much is contract SPE2DU26F0A95 worth?
The government has obligated $1,882 on SPE2DU26F0A95.
Is contract SPE2DU26F0A95 an order under another contract?
Yes. SPE2DU26F0A95 is a delivery order under SPE2DU25D9815, an indefinite delivery contract.
Was contract SPE2DU26F0A95 competed?
The extent of competition for SPE2DU26F0A95 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award